NextPlat (NXPL) Receivables - Net (2014 - 2026)
NextPlat's (NXPL) quarterly Receivables - Net came in at $8.2 million in Q2 2026, up 159.0% year-over-year from $3.2 million in Q2 2025, and up 14.16% quarter-over-quarter from $7.2 million in Q1 2026.
Analysis
NextPlat (NXPL) Receivables - Net (2014 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Receivables - Net for 13 consecutive years, with $8.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables - Net rose 159.0% year-over-year to $8.2 million in Q2 2026; TTM through Jun 2026 was $8.2 million, a 159.0% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 18.03% from the prior year.
- Receivables - Net was $8.2 million for Q2 2026 at NextPlat, up from $7.2 million in the prior quarter.
- Over five years, Receivables - Net peaked at $12.9 million in Q1 2024 and troughed at $344915.0 in Q2 2022.
- A 5-year average of $5.0 million and a median of $5.3 million in 2024 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net soared 2294.53% in 2023 and sank 69.38% in 2025, its largest moves.
- Over 5 years, Receivables - Net stood at $384000.0 in 2022, then soared by 2294.53% to $9.2 million in 2023, then slumped by 45.23% to $5.0 million in 2024, then climbed by 18.03% to $5.9 million in 2025, then jumped by 38.78% to $8.2 million in 2026.
- The last three Receivables - Net figures came in at $8.2 million (Q2 2026), $7.2 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.25 Mn |
| Mar 31, 2026 | 7.23 Mn |
| Dec 31, 2025 | 5.94 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Dec 31, 2024 | 5.04 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 10.40 Mn |
| Mar 31, 2024 | 12.93 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 600,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 384,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 344,915.00 |
| Mar 31, 2022 | 420,143.00 |
| Dec 31, 2021 | 349,836.00 |
| Sep 30, 2021 | 309,839.00 |